The second edition of The Signature, the WVU Cancer Institute’s annual report, is posted online.
The report covers 2016 highlights in cancer clinical care, prevention and control, education, and research. Special topics highlighting quality care and the latest developments of the WVU Cancer Institute include:
- a Q & A with new Cancer Institute Director Richard Goldberg
- our growth as a statewide network of cancer care
- two unique lung cancer initiatives the Cancer Institute is leading in WV
- a look at the new, state-of-the-art Bonnie’s Bus
- an innovative approach to move effective treatments from the lab to clinical research studies
- an overview of academic programs to train aspiring physicians and scientists
WVU Cancer Institute offering groundbreaking treatment for gastroenteropancreatic neuroendocrine tumors
The WVU Cancer Institute is participating in the implementation of a new drug therapy for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), a type of tumor that can form in the pancreas or in other parts of the gastrointestinal tract, including the stomach, small intestine, colon, rectum, and appendix. These life-threatening tumors can spread to other organs, such as the liver.
Meshea Poore, vice president for the Division of Diversity, Equity and Inclusion at WVU, will be the special guest at a Health Sciences Town Hall during WVU’s Diversity Week celebrations.
With severe storm approaching the East Coast, WVU reminds campus community about safety and resources
The West Virginia University Police and Office of Emergency Management urges students, faculty and staff to be prepared as the state braces for the impact of Hurricane Florence, making landfall along the East Coast later this week.